Dr. Pencho Georgiev Ambulatory For Individual Practice For Medical Aid For Clinical Hematology EOOD
- Address
- Ulitsa Perushtitsa 13b 2nd Floor, 4002 Plovdiv, Bulgaria
Dr. Pencho Georgiev Ambulatory - Clinical Hematology Research Center
Dr. Pencho Georgiev Ambulatory For Individual Practice For Medical Aid For Clinical Hematology EOOD is a specialized clinical research center focused on advancing treatment options for patients with complex hematological disorders. The center demonstrates particular expertise in conducting Phase 1 and Phase 2 clinical trials for rare blood diseases and myeloproliferative conditions, evaluating novel therapeutic approaches that address critical unmet medical needs in hematology.
- Myelodysplastic syndromes (MDS) with transfusion-dependent anemia
- Polycythemia Vera and myeloproliferative neoplasms
- Immune Thrombocytopenia (ITP) and platelet disorders
The research team at this facility is actively involved in investigating innovative therapeutic agents including elritercept for reducing red blood cell transfusion requirements, RNA interference therapies like SLN124 for managing polycythemia vera, and novel immunological treatments such as budoprutug for immune-mediated thrombocytopenia. This comprehensive approach positions the center at the forefront of developing treatments for both rare and challenging hematological conditions that significantly impact patient quality of life.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Ascentage Pharma Group Inc.2active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Ascentage Pharma Group Inc.2trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Dr. Pencho Georgiev Ambulatory For Individual Practice For Medical Aid For Clinical Hematology EOOD
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 1/2, Open-label, Dose-escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral Nuvisertib (TP-3654) in Patients with Intermediate or High-risk Primary or Secondary Myelofibrosis | Sumitomo Pharma America Inc. | Phase I | Recruiting | Oct 2023 | — |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| BUDOPRUTUG | 2 | Unknown | 2025-12-19 | 2025-12-19 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.